用替尔泊肽治疗胰岛素抵抗可改善脱发。 - Suppr

Suppr

超能文献

Treatment of insulin resistance with tirzepatide leading to improvement of hair loss.

作者信息

Gordon Emily R, Musleh Sarah, Bordone Lindsey A

机构信息

Columbia University Vagelos College of Physicians and Surgeons, New York, New York.

Anzara Health, New York, New York.

出版信息

JAAD Case Rep. 2024 Jun 11;50:123-125. doi: 10.1016/j.jdcr.2024.06.001. eCollection 2024 Aug.

DOI:10.1016/j.jdcr.2024.06.001

PMID:39135763

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11318540/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bab/11318540/657c0549d0a4/gr1.jpg

相似文献

Treatment of insulin resistance with tirzepatide leading to improvement of hair loss.用替尔泊肽治疗胰岛素抵抗可改善脱发。

JAAD Case Rep. 2024 Jun 11;50:123-125. doi: 10.1016/j.jdcr.2024.06.001. eCollection 2024 Aug.

The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome.替尔泊肽在多囊卵巢综合征管理中的潜在效用

J Clin Med. 2023 Jul 10;12(14):4575. doi: 10.3390/jcm12144575.

Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes.双重 GIP 和 GLP-1 受体激动剂替西帕肽可改善 2 型糖尿病患者的β细胞功能和胰岛素敏感性。

J Clin Endocrinol Metab. 2021 Jan 23;106(2):388-396. doi: 10.1210/clinem/dgaa863.

GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice.GIPR 激动剂介导替西帕肽在肥胖小鼠中发挥不依赖体重的胰岛素增敏作用。

J Clin Invest. 2021 Jun 15;131(12). doi: 10.1172/JCI146353.

Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis.使用双重 GIP/GLP-1 受体激动剂替西帕肽治疗 2 型糖尿病：系统评价和荟萃分析。

Diabetologia. 2022 Aug;65(8):1251-1261. doi: 10.1007/s00125-022-05715-4. Epub 2022 May 17.

Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program.在 SURPASS 临床试验项目中，用替尔泊肽治疗降低代谢综合征患者符合标准的比例：一项事后分析。

Cardiovasc Diabetol. 2024 Feb 10;23(1):63. doi: 10.1186/s12933-024-02147-9.

Perspectives on weight control in diabetes - Tirzepatide.糖尿病体重控制的观点——替尔泊肽。

Diabetes Res Clin Pract. 2023 Aug;202:110770. doi: 10.1016/j.diabres.2023.110770. Epub 2023 Jun 4.

Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial.皮下注射替西帕肽与安慰剂或司美格鲁肽对 2 型糖尿病成人胰岛功能和胰岛素敏感性的影响：一项多中心、随机、双盲、平行臂、1 期临床试验。

Lancet Diabetes Endocrinol. 2022 Jun;10(6):418-429. doi: 10.1016/S2213-8587(22)00085-7. Epub 2022 Apr 22.

The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect.双重葡萄糖依赖性胰岛素促胰岛素多肽（GIP）和胰高血糖素样肽-1（GLP-1）受体激动剂替西帕肽：一种新的代谢治疗前景。

Cardiovasc Diabetol. 2021 Nov 24;20(1):225. doi: 10.1186/s12933-021-01412-5.

The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets.肠促胰岛素共激动剂替西帕肽需要 GIPR 才能从人胰岛中分泌激素。

Nat Metab. 2023 Jun;5(6):945-954. doi: 10.1038/s42255-023-00811-0. Epub 2023 Jun 5.

引用本文的文献

Exploring the Role of GLP-1 Agents in Managing Diabetic Foot Ulcers: A Narrative and Systematic Review.探索胰高血糖素样肽-1（GLP-1）类似物在糖尿病足溃疡管理中的作用：一项叙述性和系统性综述

Wound Repair Regen. 2025 Sep-Oct;33(5):e70085. doi: 10.1111/wrr.70085.

Improvement of Recalcitrant Folliculitis Decalvans With Tirzepatide: A Case Report.替尔泊肽治疗顽固性脱发性毛囊炎的疗效：一例报告

Cureus. 2024 Dec 23;16(12):e76267. doi: 10.7759/cureus.76267. eCollection 2024 Dec.

本文引用的文献

GLP-1 agonists and hair loss: a call for further investigation.GLP-1 激动剂与脱发：呼吁进一步研究。

Int J Dermatol. 2024 Sep;63(9):1128-1130. doi: 10.1111/ijd.17246. Epub 2024 May 13.

Insulin Resistance and Acne: The Role of Metformin as Alternative Therapy in Men.胰岛素抵抗与痤疮：二甲双胍作为男性替代疗法的作用。

Pharmaceuticals (Basel). 2022 Dec 26;16(1):27. doi: 10.3390/ph16010027.

The Association of Metabolic Syndrome and Insulin Resistance in Early-Onset Androgenetic Alopecia in Males: A Case-Control Study.男性早发性雄激素性秃发中代谢综合征与胰岛素抵抗的关联：一项病例对照研究。

Indian J Dermatol. 2019 Jan-Feb;64(1):23-27. doi: 10.4103/ijd.IJD_724_16.

Is There Really Relationship between Androgenetic Alopecia and Metabolic Syndrome?雄激素性脱发与代谢综合征之间真的存在关联吗？

Dermatol Res Pract. 2015;2015:980310. doi: 10.1155/2015/980310. Epub 2015 Nov 4.

Androgenetic alopecia, metabolic syndrome, and insulin resistance: Is there any association? A case-control study.雄激素性脱发、代谢综合征与胰岛素抵抗：它们之间存在关联吗？一项病例对照研究。

Indian Dermatol Online J. 2014 Jul;5(3):276-81. doi: 10.4103/2229-5178.137776.

The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia.男性早发性雄激素性脱发患者胰岛素抵抗及代谢综合征的研究。

Eur J Dermatol. 2011 Jan-Feb;21(1):79-82. doi: 10.1684/ejd.2010.1193.

The association of insulin resistance and metabolic syndrome in early androgenetic alopecia.胰岛素抵抗与代谢综合征在早发性雄激素性脱发中的相关性。

Singapore Med J. 2010 Dec;51(12):931-6.

Androgenic alopecia and insulin resistance: are they really related?雄激素性脱发与胰岛素抵抗：二者真的相关吗？

Clin Exp Dermatol. 2009 Aug;34(6):694-7. doi: 10.1111/j.1365-2230.2008.03118.x. Epub 2009 Mar 23.

Androgenetic alopecia and insulin resistance in young men.年轻男性的雄激素性脱发与胰岛素抵抗

Clin Endocrinol (Oxf). 2009 Oct;71(4):494-9. doi: 10.1111/j.1365-2265.2008.03508.x.

Early androgenetic alopecia as a marker of insulin resistance.早期雄激素性脱发作为胰岛素抵抗的一个标志。

Lancet. 2000 Sep 30;356(9236):1165-6. doi: 10.1016/S0140-6736(00)02763-X.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验